PAR paradigm biopharmaceuticals limited..

Where are we on a deal?, page-1333

  1. 64 Posts.
    lightbulb Created with Sketch. 11
    I hear your, brother. However, I think you have to cut the company some slack in terms of what it is trying to achieve with assistance from "those in the know". Why? I think it is more complicated than simply knowing that the treatment works. It's all about mergers and acquisitions with a bunch of other professionals looking to get whatever they feel is due to them in this opportunity that PAR presents.

    What leaves us ordinary investors a bit anxious is that we are behind some sort of veil - of ignorance or incomplete information, regarding what is actually real about this opportunity (PAR) we have come upon. The incompleteness (if such a word exists) of our knowledge regarding what is our eventual future is what is getting to us. Everything might be good in terms of arrangements between PAR and "those in the know". However, PAR along its partners in negotiation are possibly also trying to navigate the markets in such a way that there is maximum benefit for them. SP might not show what we want it to show just yet. However, who is to say when exactly everything will fall into place at such a speed that we get a speeding ticket?

    As an investor, one can only hope for the best whilst also keeping clear targets.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
30.0¢
Change
0.000(0.00%)
Mkt cap ! $116.8M
Open High Low Value Volume
30.0¢ 30.5¢ 29.5¢ $56.35K 188.1K

Buyers (Bids)

No. Vol. Price($)
1 9339 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 14285 1
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.